Europe led the global biosimilar market for nearly two decades, but the U.S. is now accelerating rapidly after regulatory changes in 2024. Learn how differences in approval, pricing, and adoption shape access and cost savings today.
Europe led the global biosimilar market for nearly two decades, but the U.S. is now accelerating rapidly after regulatory changes in 2024. Learn how differences in approval, pricing, and adoption shape access and cost savings today.